Sorrento Therapeutics Inc (SRNE)

[dia76ca]

In December 2021 Sorrento stated...
"Combining OEM and in-house manufacturing capacities, Sorrento is positioning to provide 30 million COVISTIX tests per month in the near term and expand to 50 to 100 million COVISTIX tests monthly to accommodate accelerating demand globally."

Just for fun lets assume they manufacture and sell an average of 40 million tests a month in 2022. That would total 480 million tests and if they can net a very modest $2.50 per test the 2022 net profit would be $1.2 Billion.

Some may complain that worldwide sales could far exceed 40 million a month and that they can net far more than $2.50 per test. Both complaints could very well be true. But only time will tell!